CELLINK and Volumetric Release New Lumen X for Bioprinting Larger Vascular Structures
The realm of 3D printing operates on many levels, with those innovating in the medical arena constantly pushing more dynamic and complex processes forward via new hardware, 3D software, and a wide range of materials. Intense collaborations are common between industry leaders too as they bring different talents and resources forward to provide users with new capabilities. Now, CELLINK and Volumetric have teamed up to develop Lumen X, a digital light processing bioprinter, designed to enhance inventions in creating more substantial vascular structures.
Lumen X uses SLA technology in combination with patent-pending bioinks to allow scientists new tools for detailed research in futuristic tissue engineering. Remarkable for the bioprinting industry, the Lumen X is being marketed as entry-level hardware, meant to complement the recently released Holograph X, which can print features as complex as 10 microns for complex, advanced needs in the laboratory. The BIO X is another complementary hardware product, accompanied by the expansive CELLINK bioink portfolio.
“We are excited to launch yet another product in our bioprinting technology portfolio. This system will seamlessly complement our current product offerings of both hardware as well as bioinks and biomaterials. We look forward to continue offering the latest bioprinting technologies to our customers worldwide,” said Erik Gatenholm, CEO and co-founder of CELLINK.
As they delved further into the needs of bioprinting users today, melding it with the long history of SLA technology, Volumetric co-founders Drs. Jordan S. Miller and Bagrat Grigoryan completed technical development of the Lumen X. The release of this new bioprinter is the result of five years of academic research and work in validation.
“We are so thrilled to see our research, the culmination of a combined 20 years of stereolithography and 3D bioprinting expertise, developed and commercialized through this incredibly strong partnership with CELLINK,” said Dr. Miller. “Through this collaboration, we are harnessing the power and precision of light to structure living tissue through highly parallelized projection stereolithography and photopolymerization, and we see entry level applications in microfluidics, lab-on-a-chip devices, and vascularized living tissues containing millions of cells.”
Following are stats on the Lumen X:
Technology and Hardware Projection Stereolithography
- > 1 million simultaneous points of light
- Projected Image: 1280 x 800 pixels
- Pixel Resolution (XY): 50 µm
- Z-Precision (motor-driven): 5 µm
- Max Build Volume: 64 x 40 x 40 mm
Projected Light Biocompatible
- Wavelength: 405 nm Intensity
- Range: 10 – 30 mW/cm²
- Distortion: < 1%
- Disposable, quick-change sterile vats
- Heated Platform: Up to 37 °C
- Seamless, intuitive workflow
- Capacitive touch interface
- Compatible File Type: STL, stereolithography file
- Power Input: 100 – 265 VAC, 50 – 60 Hz, 100 W
Size and Weight
- Dimensions: 24 x 43 x 41 cm (9.5 x 17 x 16.5 in)
- Weight: 9 kgs (20 lbs)
Headquartered in Houston, Texas, Volumetric specializes in the creation of biomaterials and biomanufacturing processes. Founded in 2018, their continued goal is to provide scientists with the tools they need for generating and validating biological tissue from cultured human cells.
CELLINK, founded in 2016, is one of the leading 3D bioprinter and bioink companies in the world, with a current presence in over 50 countries. We have been following their progress from their first venture into universal bioink with 3D printed miniature ears to launch of their podcast, Biotech Buzz, to the release of the Bio X, and more. Their goal continues to be changing the future of medicine as researchers inch closer to being able to 3D print not only tissue, but organs also.
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source: CELLINK]
You May Also Like
An Indian Bioprinting Startup is Working on 3D Printed ‘Liquid Cornea’ for Corneal Grafts
In the last few years, there has been a continuous growth of bioprinting companies around the world, probably because the medical field is one of the most exciting industries taking...
Bioprinting 101 Part 18 – Pharmaceutical Testing
A pharmaceutical test can be referred to as a clinical trial or a rigorously controlled test of a new drug or a new invasive medical device on human subjects. In...
Tomsk Polytechnic University Researchers Study Effects of Annealing in Bioprinting for Bone Regeneration
Scientists from Tomsk Polytechnic University have recently published ‘Effect of annealing on mechanical and morphological properties of Poly(L-lactic acid)/Hydroxyapatite composite as material for 3D printing of bone tissue growth stimulating...
University of Pittsburgh: 3D Printing Mammary Glands to Study Premalignant Disease
Recently, Adrian V. Lee of University of Pittsburgh prepared a study for the U.S. Army Medical Research and Materiel Command regarding 3D printed medical models and breast cancer research. His...